Finch Therapeutics Group, Inc. (FNCH) Stock Analysis
DELISTED 2026
What happened to Finch Therapeutics Group, Inc. (FNCH) stock?
Finch Therapeutics Group, Inc. (FNCH) no longer trades on public markets. It was delisted in March 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2026
- Last recorded price (historical):
- $10.20 (last quote on record before the March 2026 delisting; historical, not a current quote)
Market cap $16.4M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Finch Therapeutics Group, Inc. (FNCH). Finch Therapeutics Group, Inc. is a clinical-stage biotechnology company focused on developing microbiome therapeutics. Their lead candidate, CP101, targets recurrent Clostridioides difficile infection and chronic hepatitis B virus.
Last analyzed: Mar 15, 2026Dated analysis: the newest financial statements on file are 31 months old (Mar 1, 2024), so the figures and score below describe that period, not today.
Finch Therapeutics Group, Inc. (FNCH) Healthcare & Pipeline Overview
FNCH OTC Market Information
FNCH trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy FNCH shares?
No. FNCH stopped trading on public markets in March 2026, so the shares are not available through a broker. Anything you see quoted for FNCH elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before FNCH stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Finch Therapeutics Group, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.